Femme et Homme
- | Pays :
- Germany
- Canada
- Belgium
- Les 16 autres...
- | Organes : -
- | Spécialités : -
Extrait
BUILD 3 is a prospective, multicenter, randomized, double-blind, parallel group, placebo-controlled, event-driven, group sequential, phase III superiority study. The primary objective is to demonstrate that bosentan delays disease worsening or death in patients with Idiopathic Pulmonary Fibrosis.
Critère d'inclusion
- Idiopathic pulmonary fibrosis